Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
0.1830
0.00 (0.00%)
Aug 1, 2025, 4:00 PM EDT
United States Steel Revenue
Renalytix had revenue of $1.25M in the quarter ending December 31, 2024, with 76.45% growth. This brings the company's revenue in the last twelve months to $2.89M, up 20.08% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.
Revenue (ttm)
2.89M
Revenue Growth
+20.08%
P/S Ratio
11.37
Revenue / Employee
28.37K
Employees
102
Market Cap
32.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 2.29M | -1.11M | -32.74% |
Jun 30, 2023 | 3.40M | 433.00K | 14.58% |
Jun 30, 2022 | 2.97M | 1.48M | 99.20% |
Jun 30, 2021 | 1.49M | - | - |
Jun 30, 2020 | - | - | - |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Renalytix News
- 12 days ago - MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities - PRNewsWire
- 4 months ago - Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire